The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: An application of latent class analysis

BMC Medical Research Methodology

Volumn 12, Issue , 2012, Pages

  Gao, Feng ^a   Miller, J Philip ^a   Miglior, Stefano ^b   Beiser, Julia A ^a   Torri, Valter ^c   Kass, Michael A ^a   Gordon, Mae O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Intraocular pressure fluctuation; Latent class analysis; Longitudinal data; Prediction model; Primary open angle glaucoma; Survival data; Time dependent covariate

Indexed keywords

ARTICLE; BLINDNESS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL; VISUAL FIELD;

BLINDNESS; COHORT STUDIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; RISK FACTORS; SURVIVAL; TONOMETRY, OCULAR; VISUAL FIELDS;

EID: 84866901499     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-12-151     Document Type: Article

References (35)

1. Number of people with glaucoma worldwide. Quigley HA, Br J Ophthalmol 1996 80 5 389 393 10.1136/bjo.80.5.389 8695555
2. Racial differences in the cause-specific prevalence of blindness in east Baltimore. Sommer A, Tielsch JM, Katz J, et al. N Engl J Med 1991 325 20 1412 1417 10.1056/NEJM199111143252004 1922252
3. US Department of Health, Education, and Welfare, Statistics on blindness in the model reporting area 1969-1970 Washington, DC: US Government Printing Office 1973
4. Models of open-angle glaucoma prevalence and incidence in the United States. Quigley HA, Vitale S, Invest Ophthalmol Vis Sci 1997 38 1 83 91 9008633
5. Prevalence and causes of visual impairment in the Barbados eye study. Hyman L, Wu SY, Connell AM, et al. Ophthalmology 2001 108 10 1751 1756 10.1016/S0161-6420(01)00590-5 11581045
6. The Framingham Eye study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Leibowitz HM, Krueger DE, Maunder LR, et al. Surv Ophthalmol 1980 24 suppl 335 610 7444756
7. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Armaly MF, Kreuger DE, Maunder L, et al. Arch Ophthalmol 1980 98 2163 2171 10.1001/archopht.1980.01020041015002 7447768
8. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Quigley HA, Enger C, Katz J, et al. Arch Ophthalmol 1994 112 644 649 10.1001/archopht.1994.01090170088028 8185522
9. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Kass MA, Heuer DK, Higginbotham EJ, et al. Arch Ophthalmol 2002 120 6 701 713 discussion 829-830 12049574
10. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Heijl A, Leske MC, Bengtsson B, et al. Arch Ophthalmol 2002 120 10 1268 1279 12365904
11. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The Advanced Glaucoma Intervention Study Group, Am J Ophthalmol 2000 130 429 440 11024415
12. Intraocular pressure fluctuations: how much do they matter? Singh K, Shrivastava A, Curr Opin Ophthalmol 2009 20 84 87 10.1097/ICU.0b013e328324e6c4 19248311
13. Understanding the importance of IOP variables in glaucoma: a systematic review. Sultan MB, Mansberger SL, Lee PP, Surv Ophthalmol 2009 54 643 662 10.1016/j.survophthal.2009.05.001 19665744
14. Nagin DS, Group-based modeling of development Cambridge: MA. Harvard University Press 2005
15. Predictive factors for open-angle glaucoma among subjects with ocular hypertension in the European glaucoma prevention study. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I, Ophthalmology 2007 114 1 3 9 17070596
16. Petras H, Masyn K, General growth mixture analysis with antecedents and consequences of change Springer: Handbook of Quantitative Criminology 2009
17. The ocular hypertension treatment study group and the European glaucoma prevention study group. A validated prediction model for the development of primary open angle glaucoma in individuals with ocular hypertension. Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA, Ophthalmology 2007 114 1 10 19 17095090
18. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Gordon MO, Beiser JA, Brandt JD, Heuer D, Higginbotham E, Johnson C, et al. Arch Ophthalmol 2002 120 714 720 12049575
19. A joint model for prognostic effect of biomarker variability on outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG). Gao F, Miller JP, Miglior S, Beiser JA, Torri V, Kass MA, Gordon MO, JP Journal of Biostatistics. 2011 5 2 73 96 22180704
20. Testing the number of components in a normal mixture. Lo Y, Mendell NR, Rubin DB, Biometrika 2001 88 767 778 10.1093/biomet/88.3.767
21. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach. Proust-Lima C, Taylor JMG, Biostatistics 2009 10 535 549 10.1093/biostatistics/kxp009 19369642
22. Latent class models for joint analysis of longitudinal biomarker and event process data: application to longitudinal prostate-specific antigen readings and prostate cancer. Lin H, Turnbull BW, Mcculloch CE, Slate EH, J Am Stat Assoc 2002 97 53 65 10.1198/016214502753479220
23. Muthén LK, Muthén BO, Mplus User's guide Los Angeles, CA: Muthén & Muthén Sixth 1998-2010 19320621
24. R Core Team, R: a language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing 2012 http://www.R-project.org/ ISBN 3-900051-07-0
25. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Miglior S, Torri V, Zeyen T, Pfeiffer N, Cunha-Vaz J, Adamsons I, Am J Ophthalmol 2007 144 266 275 10.1016/j.ajo.2007.04.040 17543874
26. Tutorial in biostatistics multivariate prognostic models: Issues in developing models, evaluation assumptions and adequacy, and measuring and reducing errors. Harrell FE Jr, Lee KL, Mark DB, Stat Med 1996 15 361 387 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 8668867
27. Advanced glaucoma intervention study. Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Ophthalmology 2004 111 9 1627 1635 10.1016/j.ophtha.2004.02.017 15350314
28. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Bengtsson BL, Leske MC, Hyman L, Heijl A, Early Manifest Glaucoma Trial Group, Ophthalmology 2007 114 205 209 10.1016/j.ophtha.2006.07.060 17097736
29. Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Caprioli J, Coleman AL, Ophthalmology 2008 115 1123 1129 10.1016/j.ophtha.2007.10.031 18082889
30. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Medeiros FA, Weinreb RN, Zangwill LM, et al. Ophthalmology 2008 115 934 940 10.1016/j.ophtha.2007.08.012 17936908
31. Random-effects models for longitudinal data. Laird NM, Ware JH, Biometrics 1982 38 963 974 10.2307/2529876 7168798
32. Advances in group-based trajectory modeling and a SAS procedure for estimating them. Jones BL, Nagin DS, Sociological Methods & Research. 2007 35 3 542 571 23169637
33. Joint modeling of longitudinal measurements and event time data. Henderson R, Diggle P, Dobson A, Biostatistics 2000 4 465 480
34. Shared parameter models for the joint analysis of longitudinal data and event times. Vonesh EF, Greene T, Schluchter MD, Statistics in Medicine 2006 25 143 163 10.1002/sim.2249 16025541
35. Dynamic prediction by landmarking in event history analysis. Van Houwelingen HC, Scand J Statist 2007 34 70 85 10.1111/j.1467-9469.2006.00529.x